Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactions

Transfusion

Volumn 58, Issue 7, 2018, Pages 1647-1653

  Bloch, Evan M ^a   Marshall, Christi E ^a   Boyd, Joan S ^a   Shifflett, Lisa ^a   Tobian, Aaron A R ^a   Gehrie, Eric A ^a   Ness, Paul M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER; APHERESIS; ARTICLE; BACILLUS CEREUS; BACILLUS MYCOIDES; BACILLUS THURINGIENSIS; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD ANALYSIS; BLOOD TRANSFUSION REACTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; GRAM NEGATIVE BACTERIUM; HUMAN; LECLERCIA ADECARBOXYLATA; MICROBACTERIUM; MICROCOCCUS LUTEUS; NONHUMAN; SEPSIS; THROMBOCYTE; BACTERIUM; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD PLATELETS; HUMANS; PLATELET TRANSFUSION; PLATELETPHERESIS; SEPSIS;

EID: 85044761875     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14618     Document Type: Article

References (35)

1. FDA. Fatalities reported to FDA following blood collection and transfusion annual summary for FY2015. Silver Spring (MD): FDA; 2015
2. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001;41:1493-9
3. Blajchman MA, Goldman M, Baeza F. Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004;18:11-24
4. McDonald CP, Roy A, Mahajan P, et al. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004;86:178-82
5. de Korte DM, Marcelis JH. Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections. Int J Clin Transf Med 2014;2:9
6. Wagner SJ, Eder AF. A model to predict the improvement of automated blood culture bacterial detection by doubling platelet sample volume. Transfusion 2007;47:430-3
7. Ramirez-Arcos S, DiFranco C, McIntyre T, et al. Residual risk of bacterial contamination of platelets: six years of experience with sterility testing. Transfusion 2017;57:2174-81
8. Jacobs MR, Good CE, Lazarus HM, et al. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;46:1214-20
9. Hong H, Xiao W, Lazarus HM, et al. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood 2016;127:496-502
10. FDA-CBER. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. 2016 [cited 2018 Mar 16]. Available from: https://www.fda.gov/downloads/Guidances/Blood/UCM425952.pdf
11. Bloch EM. Residual risk of bacterial contamination: what are the options? Transfusion 2017;57:2289-92
12. CDC. National healthcare safety network biovigilance component hemovigilance module surveillance protocol. Atlanta, GA: CDC; 2017
13. Kaiser-Guignard J, Canellini G, Lion N, et al. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates. Blood Rev 2014;28:235-41
14. Aubry M, Richard V, Green J, et al. Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 2016;56:33-40
15. Li JW, Brecher ME, Jacobson JL, et al. Addressing the risk of bacterial contamination in platelets: a hospital economic perspective. Transfusion 2017;57:2321-8
16. Butler C, Doree C, Estcourt LJ, et al. Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev 2013;3:CD009072
17. Jacobs MR, Smith D, Heaton WA, et al. Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera detection test. Transfusion 2011;51:2573-82
18. Heaton WA, Good CE, Galloway-Haskins R, et al. Evaluation of a rapid colorimetric assay for detection of bacterial contamination in apheresis and pooled random-donor platelet units. Transfusion 2014;54:1634-41
19. Verax. Platelet PGD® Test [package insert]. 2009 [cited 2018 Mar 16]. Available from: veraxbiomedical.com/pdf/US-PLatelet-PGD-Test-v2.pdf. Accessed March 16, 2018
20. Immunetics. BacTx® Bacterial Detection Kit for Platelets. Immunetics Catalog Number: DK-B502-032. 2013 [cited 2018 Mar 16]. Available from: www.interchim.fr/ft/1/1J4710.pdf
21. Jacobson J. (0230-TC) Implementation of FDA draft guidance for bacterial detection in platelets: how to choose the best option for your hospital. 2017 AABB Annual Meeting, San Diego; 2017
22. Murphy WG, Foley M, Doherty C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008;95:13-9
23. Benjamin RJ, Dy B, Perez J, et al. Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results. Vox Sang 2014;106:23-30
24. Fuller AK, Uglik KM, Braine HG, et al. A comprehensive program to minimize platelet outdating. Transfusion 2011;51:1469-76
25. Yomtovian R, Lazarus HM, Goodnough LT, et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993;33:902-9
26. Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-8
27. Ramirez-Arcos S, DiFranco C, McIntyre T, et al. Residual risk of bacterial contamination of platelets: six years of experience with sterility testing. Transfusion 2017;57:2174-81
28. Dumont LJ, Kleinman S, Murphy JR, et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50:589-99
29. Larsen CP, Ezligini F, Hermansen NO, et al. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005;88:93-7
30. Keren Y, Keshet D, Eidelman M, et al. Is Leclercia adecarboxylata a new and unfamiliar marine pathogen? J Clin Microbiol 2014;52:1775-6
31. Klein HG, Hrouda JC, Epstein JS. Crisis in the sustainability of the U.S. blood system. N Engl J Med 2017;377:1485-8
32. Wald M. Blood industry shrinks as transfusions decline. New York Times; 2014 [cited 2018 Mar 16]. Available from: http://www.nytimes.com/2014/08/23/business/blood-industry-hurt-by-surplus.html?_r=0
33. McDonald C, Allen J, Brailsford S, et al. Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure. Transfusion 2017;57:1122-31
34. Eder AF, Dy BA, DeMerse B, et al. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions. Transfusion 2017;57:2969-76
35. Su LL, Kamel H, Custer B, et al. Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture system. Transfusion 2008;48:1842-52